BAUUX
Price
$32.46
Change
+$0.07 (+0.22%)
Updated
Jul 31 closing price
Net Assets
1.24B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

BAUUX vs VSCIX

BAUUX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
BAUUX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAUUX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. BAUUX (1.24B). VSCIX pays higher dividends than BAUUX: VSCIX (1.23) vs BAUUX (0.55). BAUUX was incepted earlier than VSCIX: BAUUX (14 years) vs VSCIX (29 years). BAUUX (0.96) is less costly to investors than VSCIX (0.03). BAUUX is a more actively managed with annual turnover of: 39.00 vs. VSCIX (17.00). BAUUX has a lower initial minimum investment than VSCIX: BAUUX (1000000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. BAUUX (16.52). VSCIX return over 5 years is better than : 35.13 vs. BAUUX (15.40).
BAUUXVSCIXBAUUX / VSCIX
Total Expense Ratio0.960.033,200%
Annual Report Gross Expense Ratio0.960.033,200%
Fund Existence14 years29 years-
Gain YTD22.03014.591151%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B189B1%
Annual Yield % from dividends0.551.2345%
Returns for 1 year16.5222.5873%
Returns for 3 years13.9343.4432%
Returns for 5 years15.4035.1344%
Returns for 10 years48.41156.0731%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C